Crescendo Launches First Dx in Test Suite to Improve Care of Rheumatoid Arthritis Patients

By gauging 12 proteins, Vectra DA yields a score between 1 and 100 that quantifies RA disease activity. Rheumatologists can test patients suspected of having RA, to confirm that they have the disease. Then, after diagnosis of RA, doctors can continue to monitor patients to track how the disease progresses.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.